Atualização do Consenso em SMD 2022
DOI:
https://doi.org/10.46765/2675-374X.2023v4n1p178Palavras-chave:
Consenso, Atualização, Neoplasia MielodisplásicaResumo
The document discuss key points in the management of patients with Myelodysplastic Disease, including therapeutic strategies, the role of new drugs available as well the Hematopoietic Stem Cell Transplantation. Other issues evaluated were importance of molecular alterations since diagnosis to prognosis, use of comprehensive geriatric assessment for patient's selection, individualization of treatment, donor selection for HSCT and the role of blasts % and molecular mutations for the appropriate diagnosis.
Downloads
Publicado
28/02/2023
Como Citar
Duarte, F. B. ., Karine Sampaio Nunes Barroso, Roberto Luiz da Silva, Lívia Andrade Gurgel, João Paulo de Vasconcelos Leitão, Beatriz Stela Gomes de Souza Pitombeira, Rodolfo Daniel de Almeida Soares, Leandro de Pádua, & Gustavo Betarello. (2023). Atualização do Consenso em SMD 2022. JBMTCT, 4(1), 178. https://doi.org/10.46765/2675-374X.2023v4n1p178
Edição
Seção
Artigos
Licença
Copyright (c) 2023 JBMTCT
Este trabalho está licenciado sob uma licença Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
